Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and

Ji Chu1, Hui Zheng, Horace H Loh

  • 1Department of Pharmacology, Medical School, University of Minnesota, Minneapolis, MN 55455-0217, USA. chux0086@umn.edu

Cellular Signalling
|June 19, 2008
PubMed

Insights

Morphine tolerance may develop independently of beta-arrestin (betaArr) pathways. While DAMGO-induced mu-opioid receptor (OPRM1) desensitization requires betaArr, morphine desensitization occurs via a betaArr-independent mechanism.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Opioid tolerance is linked to mu-opioid receptor (OPRM1) desensitization, involving phosphorylation and beta-arrestin (betaArr) recruitment.
  • The precise roles of OPRM1 phosphorylation and betaArr in morphine-induced desensitization are not fully understood.

Purpose of the Study:

  • To investigate the involvement of OPRM1 phosphorylation and betaArr in DAMGO- and morphine-induced receptor desensitization.
  • To elucidate the mechanisms underlying OPRM1 desensitization and its potential contribution to opioid tolerance.

Main Methods:

  • Utilized intracellular calcium ([Ca(2+)](i)) release as a readout for OPRM1 activation and desensitization.
  • Employed OPRM1 phosphorylation-deficient mutants (e.g., OPRM1S375A) and betaArr1/2 knockout mouse embryonic fibroblast (MEF) cells.
  • Compared desensitization induced by DAMGO and morphine in various cell systems.

Main Results:

  • DAMGO-induced OPRM1 desensitization was dependent on both OPRM1 phosphorylation and betaArr (betaArr1 and betaArr2).
  • Morphine induced rapid OPRM1 desensitization and Ser(375) phosphorylation, but this process was independent of OPRM1 phosphorylation sites and betaArr.
  • Morphine-induced OPRM1 desensitization occurred via a betaArr-independent pathway.

Conclusions:

  • Morphine can desensitize the mu-opioid receptor (OPRM1) through a mechanism that does not require beta-arrestin (betaArr).
  • This suggests that in vivo tolerance to morphine can develop even in the absence of betaArr.
  • Highlights distinct signaling pathways for different opioid agonists in OPRM1 desensitization.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...